Management of Hyperglycemia in Type 2 Diabetes, 2022
September 22, 2022
Country of Publication
The American Diabetes Association and the European Association for the Study of Diabetes convened a panel to update the previous consensus statements on the management of hyperglycaemia in type 2 diabetes in adults, published since 2006 and last updated in 2019. The target audience is the full spectrum of the professional healthcare team providing diabetes care in the USA and Europe. A systematic examination of publications since 2018 informed new recommendations. These include additional focus on social determinants of health, the healthcare system and physical activity behaviours including sleep. There is a greater emphasis on weight management as part of the holistic approach to diabetes management. The results of cardiovascular and kidney outcomes trials involving sodium–glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists,
including assessment of subgroups, inform broader recommendations for cardiorenal protection in people with diabetes at high risk of cardiorenal disease. After a summary listing of consensus recommendations, practical tips for implementation are provided.
Male, Female, Adult, Older adult
Health Care Settings
Nurse, nurse practitioner, physician, physician assistant
Assessment and screening, Management
D003920 - Diabetes Mellitus, D003924 - Diabetes Mellitus, Type 2, D006943 - Hyperglycemia
diabetes, diabetes mellitus, type 2 diabetes mellitus, hyperglycemia
Davies MJ, Aroda VR, Collins BS, Gabbay RA, Green J, Maruthur NM, Rosas SE, Del Prato S, Mathieu C, Mingrone G, Rossing P, Tankova T, Tsapas A, Buse JB. Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2022 Sep 23:dci220034. doi: 10.2337/dci22-0034. Epub ahead of print. PMID: 36148880.